Showing results (211-220 of 296) with videos related to
Sort By:
Pageof 30
Journal of Clinical Medicine|September 2, 2020
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk FactorsAntonio Vena, Marco Berruti, Andrea Adessi, et al.European Urology Oncology|July 11, 2025
Evaluating Treatment Efficacy in Metastatic Hormone-sensitive Prostate Cancer Patients with Visceral Disease: A Systematic Review and Network Meta-analysisFabiano Flauto, Giuseppe Neola, Carmine Caso, et al.Cancers|June 2, 2021
Development of Exhaustion and Acquisition of Regulatory Function by Infiltrating CD8+CD28- T Lymphocytes Dictate Clinical Outcome in Head and Neck CancerDaniela Fenoglio, Liliana Belgioia, Alessia Parodi, et al.Infectious Diseases and Therapy|August 2, 2025
A Cluster Randomized Study to Explore Case Definitions, Clinical Course and Consequences of RSV in Community-Dwelling Adults Aged ≥ 50 YearsAlexander Domnich, Francesco Lapi, Andrea Orsi, et al.Infectious Diseases and Therapy|June 23, 2025
Deep Learning for the Early Diagnosis of CandidemiaDaniele Roberto Giacobbe, Sabrina Guastavino, Anna Razzetta, et al.Vaccines|November 11, 2022
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 VaccinationChiara Dentone, Daniela Fenoglio, Marta Ponzano, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 15, 2021
Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapyElisabetta Signoriello, Giacomo Lus, Simona Bonavita, et al.Haematologica|October 4, 2017
Steroid treatment of acute graft-<i>versus</i>-host disease grade I: a randomized trialAndrea Bacigalupo, Giuseppe Milone, Alessandra Cupri, et al.JAMA Neurology|September 14, 2020
Association of Pregnancy With the Onset of Clinically Isolated SyndromeAi-Lan Nguyen, Karolina Vodehnalova, Tomas Kalincik, et al.Cancer Immunology, Immunotherapy : CII|August 5, 2021
Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trialGilberto Filaci, Daniela Fenoglio, Franco Nolè, et al.Pageof 30